Kinase-Inactivated EGFR Is Required for the Survival of Wild-Type EGFR-Expressing Cancer Cells Treated with Tyrosine Kinase Inhibitors

Ítems similars

• Targeted reduction of the EGFR protein, but not inhibition of its kinase activity, induces mitophagy and death of cancer cells through activation of mTORC2 and Akt
  per: Katreddy, Rajasekhara Reddy, et al.
  Publicat: (2018)
• Rethink of EGFR in Cancer With Its Kinase Independent Function on Board
  per: Thomas, Rintu, et al.
  Publicat: (2019)
• T cell survival and function requires the c-Abl tyrosine kinase
  per: Silberman, Isabelle, et al.
  Publicat: (2008)
• Mean platelet volume and lymphocyte-to-monocyte ratio are associated with shorter progression-free survival in EGFR-mutant lung adenocarcinoma treated by EGFR tyrosine kinase inhibitor
  per: Watanabe, Kousuke, et al.
  Publicat: (2018)
• Survival and prognosis analyses of concurrent PIK3CA mutations in EGFR mutant non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors
  per: Qiu, Xiaotong, et al.
  Publicat: (2021)